Our findings that LMW-F reduces Bcl-2 phosphorylation at Thr56 and downregulates Bcl-2 expression in melanoma cells are consistent with previous studies indicating that inhibiting Bcl-2 phosphorylation can overcome resistance mechanisms [19,30–32]. The gene discussed is BCL2; the disease is melanoma.